TIA1 and neoplasm: When TIA1 was silenced, BCG lost its efficacy: Sh-mTia1 tumors retained intense photon flux (Figure 7B), persistent tumor architecture (Figure 7C), high LDHA/HK2/PKM2 levels (Figure 7E), and unaltered lactate output.